Gadolinium ethoxybenzyl DTPA clinical trials
Also written Eovist, Gadoxetate disodium and ZK 139834.
How each study uses gadolinium ethoxybenzyl DTPA is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the gadolinium ethoxybenzyl DTPA studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 3 Jul 2008 · EOVIST · NDA 022090 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
13 studies that test it; most in 2013 (2)
| Year | Studies |
|---|---|
| 2007 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2021 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 4 · Other 9
Bayer (3) · M.D. Anderson Cancer Center (1) · National Cancer Institute (NCI) (1) · Duke University (1) · Sara Varea (1) · University of Southern California (1) · Guerbet (1) · University of Colorado, Denver (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses gadolinium ethoxybenzyl DTPA is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 13
- Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 YearsRecruitingPhase 4GuerbetNCT04373564Written as Gadoxetate disodiumHow we know
- Comparison of Contrast Agents in Liver Magnetic Resonance (MR) for the Detection of Hepatic MetastasesTerminatedPhase 4University of Colorado, DenverNCT04973007Written as Gadoxetate disodiumHow we know
- Contrast-enhanced MRI in Detecting Benign and Malignant Liver LesionsActive, not recruitingNot applicableM.D. Anderson Cancer CenterNCT02156739Written as Gadoxetate DisodiumHow we know
- Improving CBCT for Liver IG-SBRT Using Gadoxetate DisodiumWithdrawnPhase 4Slawa CwajnaNCT03215355Written as PrimovistHow we know
- Gadoxetate Enhanced Imaging Study to Detect Prostate CancerCompletedPhase 2National Cancer Institute (NCI)NCT01867424Written as EovistHow we know
- Gadoxetate Sodium Enhanced MRI as a Biomarker for Aggressive Prostate CancerStatus unknownEarly Phase 1University of CincinnatiNCT03960788Written as Gadoxetate SodiumHow we know
- Eovist vs. Dotarem Healthy Volunteer MRICompletedPhase 4Duke UniversityNCT02431598Written as gadoxetate disodiumHow we know
- Magnetic Resonance Imaging of the Liver in Children 0-2 Months of Age With an Intravenous Injection of Eovist/Primovist Which is a Contrast AgentTerminatedPhase 3BayerNCT02084628Written as Gadoxetate disodium (Eovist/Primovist, BAY86-4873)How we know
- Magnetic Resonance With Gadoxetic Acid for the Diagnosis of Hepatocellular Carcinoma in Patients With Liver Cirrhosis. Evaluation of Its Impact for the Non-invasive DiagnosisCompletedPhase 4Sara VareaNCT01575574Written as GADOXETIC ACIDHow we know
- MRI With Gadoxetate Disodium in Measuring Tumors in Patients With Liver CancerCompletedPhase 1University of Southern CaliforniaNCT02578602Written as Gadoxetate DisodiumHow we know
- 24hr Imaging Of HCC After EOVISTWithdrawnEarly Phase 1Massachusetts General HospitalNCT01968629Written as EovistHow we know
- Primovist / Eovist in Renally Impaired PatientsCompletedPhase 4BayerNCT00908596Written as Gadoxetic acid disodium (Primovist, BAY86-4873)How we know
- Efficacy and Safety of Primovist in Chinese PatientsCompletedPhase 3BayerNCT00526188Written as Gadoxetic Acid Disodium (Primovist, BAY86-4873)How we know
Codes
What other systems call gadolinium ethoxybenzyl DTPA · ClinicalTrials.gg INT003622
- MeSH (NLM) C073590gadolinium ethoxybenzyl DTPAConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 3QJA87N40SGADOXETIC ACIDConfirmed FDA, NLM
- RxNorm 802624One source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C073590 | gadolinium ethoxybenzyl DTPA | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 3QJA87N40S | GADOXETIC ACID | Confirmed FDA, NLM |
| RxNorm | 802624 | — | One source FDA |
Also registered as gadoxetate disodium (UNII HOY74VZE0M · RxNorm 637320).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.